CS207191A3 - Derivatives of mevinic acid substituted by sulfur and process for preparing thereof - Google Patents

Derivatives of mevinic acid substituted by sulfur and process for preparing thereof Download PDF

Info

Publication number
CS207191A3
CS207191A3 CS912071A CS207191A CS207191A3 CS 207191 A3 CS207191 A3 CS 207191A3 CS 912071 A CS912071 A CS 912071A CS 207191 A CS207191 A CS 207191A CS 207191 A3 CS207191 A3 CS 207191A3
Authority
CS
Czechoslovakia
Prior art keywords
acid
methyl
decahydro
hydroxy
oxo
Prior art date
Application number
CS912071A
Other languages
Czech (cs)
English (en)
Inventor
Ravi K Varma
Jeffrey O Saunders
Sam T Chao
Eric M Gordon
Dinos P Santafianos
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of CS207191A3 publication Critical patent/CS207191A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/65Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
CS912071A 1990-07-06 1991-07-04 Derivatives of mevinic acid substituted by sulfur and process for preparing thereof CS207191A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54902490A 1990-07-06 1990-07-06

Publications (1)

Publication Number Publication Date
CS207191A3 true CS207191A3 (en) 1992-04-15

Family

ID=24191347

Family Applications (1)

Application Number Title Priority Date Filing Date
CS912071A CS207191A3 (en) 1990-07-06 1991-07-04 Derivatives of mevinic acid substituted by sulfur and process for preparing thereof

Country Status (20)

Country Link
EP (1) EP0465265A1 (es)
JP (1) JPH04230357A (es)
KR (1) KR920002571A (es)
CN (1) CN1058585A (es)
AU (1) AU647492B2 (es)
CA (1) CA2046171A1 (es)
CS (1) CS207191A3 (es)
FI (1) FI913285A (es)
HU (1) HUT58682A (es)
IE (1) IE912312A1 (es)
IL (1) IL98721A0 (es)
MX (1) MX9100095A (es)
MY (1) MY106564A (es)
NO (1) NO912636L (es)
NZ (1) NZ238848A (es)
PL (2) PL290954A1 (es)
PT (1) PT98246A (es)
RU (1) RU2041205C1 (es)
TW (1) TW227552B (es)
ZA (1) ZA915171B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
US6043064A (en) * 1993-10-22 2000-03-28 Bristol-Myers Squibb Company Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof
GB2329334A (en) * 1997-09-18 1999-03-24 Reckitt & Colmann Prod Ltd Cholesterol-lowering agents
WO2019076269A1 (zh) 2017-10-16 2019-04-25 清华大学 甲羟戊酸通路抑制剂及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US4866090A (en) * 1988-01-07 1989-09-12 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
FI893004A (fi) * 1988-06-29 1989-12-30 Merck & Co Inc 5-oxygenerade hmg-coa-reduktas -inhibitorer.
EP0415488B1 (en) * 1989-08-31 1994-04-20 Merck & Co. Inc. 7-Substituted HMG-COA reductase inhibitors

Also Published As

Publication number Publication date
FI913285A0 (fi) 1991-07-05
IL98721A0 (en) 1992-07-15
PL295149A1 (en) 1992-11-30
RU2041205C1 (ru) 1995-08-09
JPH04230357A (ja) 1992-08-19
NO912636D0 (no) 1991-07-05
IE912312A1 (en) 1992-01-15
CN1058585A (zh) 1992-02-12
MX9100095A (es) 1992-02-28
AU647492B2 (en) 1994-03-24
FI913285A (fi) 1992-01-07
ZA915171B (en) 1992-06-24
PT98246A (pt) 1992-05-29
NO912636L (no) 1992-01-07
HU912287D0 (en) 1991-12-30
HUT58682A (en) 1992-03-30
TW227552B (es) 1994-08-01
CA2046171A1 (en) 1992-01-07
PL290954A1 (en) 1992-11-16
KR920002571A (ko) 1992-02-28
EP0465265A1 (en) 1992-01-08
MY106564A (en) 1995-06-30
NZ238848A (en) 1993-06-25
AU8012091A (en) 1992-01-09

Similar Documents

Publication Publication Date Title
EP2380874B1 (en) Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP0267878A1 (en) N9-cyclopentyl-substituted adenine derivatives
AU2007207481A1 (en) Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
IL108633A (en) History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them
FI93643B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi
SI9111318A (en) Acetamide derivatives
DK170443B1 (da) Optisk aktive 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylsyreforbindelser samt mellemprodukter ved deres fremstilling
CZ297803B6 (cs) Analogy illudinu a farmaceutický prostredek
NO148416B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-, morfolin- og tiazan-derivater
CS207191A3 (en) Derivatives of mevinic acid substituted by sulfur and process for preparing thereof
EP0358305A1 (en) Mercapto-phenylalcanoylamino acid amides, their preparation and their use as collagenase inhibitors
US4882316A (en) Pyrimidine derivatives
AU2004299131B2 (en) Process for synthesizing disulfides
US5264455A (en) Sulfur-substituted mevinic acid derivatives
US5177104A (en) 6-α-hydroxy derivatives of mevinic acids
PT89244B (pt) Processo de preparacao de derivados de tioformamida terapeuticamente activos e de seus intermediarios
US5089523A (en) Fluorinated derivatives of mevinic acids
US5006546A (en) Imidazole derivatives
US3082210A (en) New 10-(azetidinyl-alkyl)phenthiazines
NO167799B (no) Analogifremgangsmaate for fremstilling av leukotrienantagonister.
US4622422A (en) Cyclohexanealkanoic acids
PL163376B1 (pl) S p osób w y tw a r z a n ia p o ch o d n y ch p e n e m u PL PL PL
US4855323A (en) Leukotriene antagonists, a process for the preparation thereof, and the use thereof for the treatment of diseases
EP0278732B1 (en) Fluorine-containing vitamin d2 derivatives
KR920002132B1 (ko) 항균성 2-카르바페넴 유도체